Veradigm (MDRX) 8-K Allscripts Reports Second Quarter 2005 Results

Exhibit 99.1

Allscripts Contacts: Dan Michelson Chief Marketing Officer 312-506-1217 dan.michelson@allscripts.com Bill Davis Chief Financial Officer 312-506-1211 bill.davis@allscripts.com

FOR IMMEDIATE RELEASE

Allscripts Reports Second Quarter 2005 Results

Software and Related Services Revenue Increases by 62.5% Over Prior Year

CHICAGO, IL – July 26, 2005 –Allscripts Healthcare Solutions (Nasdaq: MDRX), the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare, announced its results for the three and six months ended June 30, 2005.

Total revenue for the three months ended June 30, 2005, was $29.5 million, compared to $25.6 million for the same period last year. Revenue from software and related services for the three months ended June 30, 2005, was $16.1 million, compared to $9.9 million for the same period last year, increasing by approximately 62.5%.

Gross margin percentage was approximately 47.0% for the second quarter of 2005, compared to 39.4% during the second quarter of 2004.

Net income for the three months ended June 30, 2005, was $2.0 million, or $0.05 per diluted share, compared to net income of $0.7 million, or $0.02 per diluted share, for the same period last year.

As of June 30, 2005, the Company had cash and marketable securities of $134.9 million.

“Our growing sales and bottom line are a result of continued execution on our business model across our electronic health record, physician education and medication services offerings,” commented Glen Tullman, Chief Executive Officer of Allscripts. “Working closely with our clients, we are leading the market in informing and connecting physicians and patients to other healthcare stakeholders, which is the key to transforming healthcare. And, the value of each of our clients, as reference sites and prospects for innovative new products, such as TouchWorks iHealth, continues to grow. Every day we are making progress toward our vision of becoming an indispensable part of the way physicians practice medicine.”

Total revenue for the six months ended June 30, 2005, was $55.7 million, compared to $48.8 million for the six months ended June 30, 2004. Revenue from software and related services for the six months ended June 30, 2005, was $30.5 million, compared to $18.8 million for the same period last year, increasing by approximately 61.7%.

Gross margin percentage was approximately 46.7% for the six months ended June 30, 2005, compared to 39.4% for the six months ended June 30, 2004.

Net income for the six months ended June 30, 2005, was $3.4 million, or $0.08 per diluted share, compared to net income of $1.0 million, or $0.02 per diluted share, for the same period last year.

Allscripts will conduct a conference call on Tuesday, July 26, 2005, at 4:30 PM eastern time. The conference call can be accessed by dialing 1-800-374-0526, or via the Internet at www.allscripts.com. A recording of the conference call will be available for review through August 9, 2005, at www.allscripts.com or by calling 1-800-642-1687, ID # 7815470.

About Allscripts

Allscripts Healthcare Solutions is the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare. The Company provides unique solutions that inform, connect and transform healthcare. The Clinical Solutions Group’s award-winning clinical software applications include Electronic Health Record, e-prescribing and document imaging solutions. Allscripts’ Physicians Interactive Group provides clinical product education and connectivity solutions for physicians and patients. The Company’s Medication Services Group provides medication fulfillment services. To learn more, visit Allscripts on the Web at www.allscripts.com.

This announcement may contain forward-looking statements about Allscripts Healthcare Solutions that involve risks and uncertainties. These statements are developed by combining currently available information with Allscripts beliefs and assumptions. Forward-looking statements do not guarantee future performance. Because Allscripts cannot predict all of the risks and uncertainties that may affect it, or control the ones it does predict, Allscripts’ actual results may be materially different from the results expressed in its forward-looking statements. For a more complete discussion of the risks, uncertainties and assumptions that may affect Allscripts, see the Company’s 2004 Annual Report on Form 10-K, available through the Web site maintained by the Securities and Exchange Commission at www.sec.gov.

Allscripts Healthcare Solutions, Inc.

Condensed Consolidated Statements of Operations

(amounts in thousands, except per-share amounts)

(Unaudited)

	Three Months Ended June 30,						Six Months Ended June 30,
	2005			2004			2005			2004
Revenue:
Prepackaged medications	$	11,489		$	12,396		$	21,324		$	23,580
Software and related services		16,145			9,934			30,455			18,829
Information services		1,900			3,278			3,950			6,354
Total revenue		29,534			25,608			55,729			48,763
Cost of revenue:
Prepackaged medications		9,697			10,054			17,420			18,807
Software and related services		5,231			3,611			10,485			7,123
Information services		725			1,854			1,776			3,598
Total cost of revenue		15,653			15,519			29,681			29,528
Gross profit		13,881			10,089			26,048			19,235
Operating expenses:
Selling, general and administrative expenses		11,458			9,103			21,815			17,863
Amortization of intangibles		436			445			872			874
Income from operations		1,987			541			3,361			498
Interest expense		(898	)		—			(1,805	)		—
Interest income		957			220			1,834			437
Other income (expense), net		(13	)		(65	)		(23	)		28
Income before income taxes		2,033			696			3,367			963
Income taxes		—			—			—			—
Net income		$2,033			$696			$3,367			$963
Net income per share - basic		$0.05			$0.02			$0.09			$0.02
Net income per share - diluted		$0.05			$0.02			$0.08			$0.02
Weighted average shares of common stock outstanding used in computing basic net income per share		39,824			39,469			39,451			39,319
Weighted average shares of common stock outstanding used in computing diluted net income per share		43,144			42,431			42,585			42,113

Allscripts Healthcare Solutions, Inc.

Condensed Consolidated Balance Sheets

(amounts in thousands)

	June 30, 2005		December 31, 2004
	(Unaudited)
Assets
Current assets
Cash and cash equivalents		$36,779	$16,972
Marketable securities		44,814	22,796
Accounts receivable, net		23,323	21,382
Other receivables		671	627
Inventories		1,929	2,372
Prepaid expenses and other current assets		3,733	3,571
Total current assets		111,249	67,720
Long-term marketable securities		53,286	88,471
Software development costs, net		6,181	6,270
Fixed assets, net		2,482	2,366
Intangible assets, net		23,753	24,546
Other assets		5,349	4,804
Total assets	$	202,300	$194,177
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable		$4,693	$5,981
Accrued expenses		12,788	12,218
Deferred revenue		14,444	14,607
Total current liabilities		31,925	32,806
Other liabilities		348	178
Long-term debt		82,500	82,500
Total liabilities		114,773	115,484
Stockholders’ equity		87,527	78,693
Total liabilities and stockholders’ equity	$	202,300	$194,177